Results 161 to 170 of about 178,801 (195)

Outcome of Chagas Cardiomyopathy in Comparison to Ischemic Cardiomyopathy

International Journal of Cardiology, 2013
Chagas cardiomyopathy and ischemic heart disease (IHD) are frequent causes of chronic systolic heart failure (CHF) in areas where the former is endemic. Nonetheless, a specific comparison of outcome and role of etiology of CHF failure has not been performed in patients with both conditions.Two-hundred twenty two patients with Chagas cardiomyopathy and ...
Augusto Cardinalli-Neto, Ana Paula Otaviano   +1 more
exaly   +3 more sources

Heart transplantation for chagas' cardiomyopathy

The Annals of Thoracic Surgery, 1995
We present 2 patients who underwent orthotopic heart transplantation for end-stage Chagas' cardiomyopathy. Despite immunosuppressive therapy, postoperative prophylaxis with nifurtimox appeared to prevent Trypanosoma cruzi reactivation. Neither patient has shown signs of Chagas' myocarditis, and both are clinically well 12 and 72 months after ...
C, Blanche, I, Aleksic, J J, Takkenberg, L S, Czer, M C, Fishbein, A, Trento   +5 more
openaire   +2 more sources

Chagas’ cardiomyopathy

2018
Abstract Chagas’ cardiomyopathy is a major complication emerging from Trypanosoma cruzi infection, appearing in up to 30% of individuals with positive serology and being the principal cause of death from heart failure in some areas of South America.
Carlos Eduardo Rochitte, Otávio Rizzi Coelho-Filho   +1 more
openaire   +1 more source

An update on the management of Chagas cardiomyopathy

Expert Review of Anti-infective Therapy, 2007
Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, infects nearly 18 million people in Latin America and mainly affects the heart, causing heart failure, arrhythmias, heart block, thromboembolism, stroke and death. In this review, the clinical diagnosis and management of Chagas cardiomyopathy are discussed.
Manoel O C, Rocha, Mauro M, Teixeira, Antonio L, Ribeiro   +2 more
openaire   +2 more sources

Diagnosis and Management of Chagas Disease and Cardiomyopathy

Nature Reviews Cardiology, 2012
Chagas cardiomyopathy is the most severe and life-threatening manifestation of human Chagas disease--a 'neglected' tropical disease caused by the protozoan parasite Trypanosoma cruzi. The disease is endemic in all continental Latin American countries, but has become a worldwide problem because of migration of infected individuals to developed countries,
Mauro M Teixeira, Manoel O C Rocha
exaly   +3 more sources

Chagas Cardiomyopathy in Latin America Review

Current Cardiology Reports, 2019
Chagas cardiomyopathy is a major public health disease in Latin America and, due to migration, is becoming a worldwide health and economic burden. This review sought to present the clinical and epidemiological aspects of Chagas cardiomyopathy, as well as some specific features and principles of treatment.
Juan Alberto Cosquillo Mejia, Jefferson Luis Vieira, Glauber Gean Vasconcelos   +2 more
exaly   +3 more sources

Clinical management of chronic Chagas cardiomyopathy

Frontiers in Bioscience, 2003
Chagas disease is caused by a protozoan parasite, Trypanosoma cruzi, and infects over 15 million people worldwide. New cases of the disease are now uncommon, mainly due to national control programs in Latin America. However, there is a large reservoir of chronically infected patients, many of whom will develop chagasic cardiopathy.
Manoel O C, Rocha, Antonio Luiz P, Ribeiro, Mauro M, Teixeira   +2 more
openaire   +2 more sources

Chagas cardiomyopathy and ischemic stroke

Expert Review of Cardiovascular Therapy, 2006
American trypanosomiasis, known as Chagas disease is a major cause of cardiomyopathy in South America. Irreversible damage to the heart can appear 10-20 years after chagasic infection. The relationship between Chagas cardiomyopathy and ischemic stroke has been reviewed.
openaire   +2 more sources

Comparative Prognosis of Chagas and Other Cardiomyopathies

JACC
Chagas disease, caused by Trypanosoma cruzi parasites, is a common cause of heart failure (HF) in Latin America, and has recently been declared endemic in the USA. We compared outcomes in Chagasic HF to ischemic and other non-ischemic etiologies of HF with reduced ejection fraction (HFrEF).To compare clinical outcomes of Chagasic HFrEF with ischemic ...
Ryohei Ono, Kieran F. Docherty, Alasdair D. Henderson, Luis E. Echeverria, G. Michael Felker, Renato D. Lopes, Felipe Martinez, Milton Packer, Felix J.A. Ramires, John R. Teerlink, Muthiah Vaduganathan, Michael R. Zile, Pardeep S. Jhund, Scott D. Solomon, John J.V. McMurray   +14 more
openaire   +2 more sources

Chagas Cardiomyopathy

Cardiology Clinics, 2017
Catherine Pastorius Benziger, Gabriel Assis Lopes do Carmo, Antonio Luiz Pinho Ribeiro   +2 more
openaire   +2 more sources